About: Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $31.87 (-2.89%)
ARQT NASDAQ Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics Inc share price
Atividade de preço de ARQT
Último preço
$ 31,870
Variação (24h)
-0,95 USD (2,89%)
Volume
1.68M
Volume (média 4 sem.)
-
Abertura
$ 32,64
Variação do dia
$ 31,65 - $ 32,94
Fechamento anterior
$ 32,82
Último negócio
21 Oct, 8:16 pm GMT+0
Atrasado
21 Oct, 8:16 pm GMT+0
ARQT price performance
Atrasado
21 Oct, 8:16 pm GMT+0
quote.marketSignals